These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18059372)

  • 21. An essential role for TAK1 in the contact hypersensitivity response.
    Zhao YG; Wang Y; Hao W; Wan YY
    Cell Mol Immunol; 2011 Jul; 8(4):315-24. PubMed ID: 21552285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intradermal injection of monocyte chemoattractant protein-1 induces emigration and differentiation of blood monocytes in rat skin.
    Yamashiro S; Takeya M; Kuratsu J; Ushio Y; Takahashi K; Yoshimura T
    Int Arch Allergy Immunol; 1998 Jan; 115(1):15-23. PubMed ID: 9430491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
    Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
    Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous or oral administration of rhIL-11 modulated the contact hypersensitivity response.
    Peterson RL; Wang LL; Albert L; Dorner AJ
    Cytokine; 2000 Dec; 12(12):1769-77. PubMed ID: 11097746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of regulatory T cells by leflunomide in a murine model of contact allergen sensitivity.
    Weigmann B; Jarman ER; Sudowe S; Bros M; Knop J; Reske-Kunz AB
    J Invest Dermatol; 2006 Jul; 126(7):1524-33. PubMed ID: 16543898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1.
    Rand ML; Warren JS; Mansour MK; Newman W; Ringler DJ
    Am J Pathol; 1996 Mar; 148(3):855-64. PubMed ID: 8774140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation.
    de Borst MH; Prakash J; Sandovici M; Klok PA; Hamming I; Kok RJ; Navis G; van Goor H
    J Pharmacol Exp Ther; 2009 Dec; 331(3):896-905. PubMed ID: 19717791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cells and T cells induce different types of skin reactions during recall responses to haptens.
    Rouzaire P; Luci C; Blasco E; Bienvenu J; Walzer T; Nicolas JF; Hennino A
    Eur J Immunol; 2012 Jan; 42(1):80-8. PubMed ID: 21968602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocyte chemoattractant protein-1 (MCP-1) inhibits the intestinal-like differentiation of monocytes.
    Spoettl T; Hausmann M; Herlyn M; Gunckel M; Dirmeier A; Falk W; Herfarth H; Schoelmerich J; Rogler G
    Clin Exp Immunol; 2006 Jul; 145(1):190-9. PubMed ID: 16792690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced contact hypersensitivity by delayed T-helper 2 response in BALB/c mice.
    Hayashi T; Hara S; Hasegawa K
    Allergy Asthma Proc; 2009; 30(4):449-57. PubMed ID: 19772766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance.
    Riemann H; Schwarz A; Grabbe S; Aragane Y; Luger TA; Wysocka M; Kubin M; Trinchieri G; Schwarz T
    J Immunol; 1996 Mar; 156(5):1799-803. PubMed ID: 8596029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of CXCR2 activity in the contact hypersensitivity response in mice.
    Cattani F; Gallese A; Mosca M; Buanne P; Biordi L; Francavilla S; Coletti G; Pellegrini L; Melillo G; Bertini R
    Eur Cytokine Netw; 2006 Mar; 17(1):42-8. PubMed ID: 16613762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced CD4+ forkhead box protein-positive T cells inhibit mast cell function and established contact hypersensitivity through TGF-β1.
    Su W; Fan H; Chen M; Wang J; Brand D; He X; Quesniaux V; Ryffel B; Zhu L; Liang D; Zheng SG
    J Allergy Clin Immunol; 2012 Aug; 130(2):444-52.e7. PubMed ID: 22738679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
    Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
    Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles.
    Yao Z; Keeney M; Lin TH; Pajarinen J; Barcay K; Waters H; Egashira K; Yang F; Goodman S
    J Biomed Mater Res A; 2014 Sep; 102(9):3291-7. PubMed ID: 24123855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a topical steroid on gene expressions for chemokines in mice with contact hypersensitivity.
    Mitsui G; Hirano T; Niwano Y; Mitsui K; Ohara O; Yanagihara S; Kato M
    Int Immunopharmacol; 2004 Jan; 4(1):57-69. PubMed ID: 14975360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin.
    Yu X; Barnhill RL; Graves DT
    Lab Invest; 1994 Aug; 71(2):226-35. PubMed ID: 8078302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of interleukin-16 in murine contact hypersensitivity.
    Masuda K; Katoh N; Soga F; Kishimoto S
    Clin Exp Immunol; 2005 May; 140(2):213-9. PubMed ID: 15807844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of PD-L2/B7-DC by Topical Application of Small Interfering RNA Inhibits Elicitation of Contact Hypersensitivity.
    Furusawa E; Ohno T; Nagai S; Noda T; Komiyama T; Kobayashi K; Hamamoto H; Miyashin M; Yokozeki H; Azuma M
    J Invest Dermatol; 2019 Oct; 139(10):2164-2173.e1. PubMed ID: 30978356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.